Dixon M, Millington C, Bernstein L, Coughlin 2nd C, Drumm M, Gaughan S
JIMD Rep. 2024; 65(3):188-203.
PMID: 38736635
PMC: 11078710.
DOI: 10.1002/jmd2.12418.
Coughlin 2nd C, Tseng L, van Karnebeek C
Cold Spring Harb Mol Case Stud. 2022; 8(2).
PMID: 35217564
PMC: 8958922.
DOI: 10.1101/mcs.a006197.
Li Y, Ghanbari R, Pathmasiri W, McRitchie S, Poustchi H, Shayanrad A
Front Nutr. 2021; 7:584585.
PMID: 33415121
PMC: 7783045.
DOI: 10.3389/fnut.2020.584585.
Nishiyama M, Nakamichi N, Yoshimura T, Masuo Y, Komori T, Ishimoto T
Neurochem Res. 2020; 45(11):2664-2678.
PMID: 32844295
DOI: 10.1007/s11064-020-03118-8.
Xue J, Wang J, Gong P, Wu M, Yang W, Jiang S
Sci Rep. 2019; 9(1):11371.
PMID: 31388081
PMC: 6684619.
DOI: 10.1038/s41598-019-47882-2.
Clinical diagnosis, treatment, and ALDH7A1 mutations in pyridoxine-dependent epilepsy in three Chinese infants.
Yang Z, Yang X, Wu Y, Wang J, Zhang Y, Xiong H
PLoS One. 2014; 9(3):e92803.
PMID: 24664145
PMC: 3963937.
DOI: 10.1371/journal.pone.0092803.
Pyridoxine responsiveness in novel mutations of the PNPO gene.
Plecko B, Paul K, Mills P, Clayton P, Paschke E, Maier O
Neurology. 2014; 82(16):1425-33.
PMID: 24658933
PMC: 4001193.
DOI: 10.1212/WNL.0000000000000344.
Metabolic profiling framework for discovery of candidate diagnostic markers of malaria.
Tritten L, Keiser J, Godejohann M, Utzinger J, Vargas M, Beckonert O
Sci Rep. 2013; 3:2769.
PMID: 24067624
PMC: 6505674.
DOI: 10.1038/srep02769.
Long-Term Follow-up of a Successfully Treated Case of Congenital Pyridoxine-Dependent Epilepsy.
Proudfoot M, Jardine P, Straukiene A, Noad R, Parrish A, Ellard S
JIMD Rep. 2013; 10:103-6.
PMID: 23430810
PMC: 3755577.
DOI: 10.1007/8904_2012_210.
The measurement of urinary Δ¹-piperideine-6-carboxylate, the alter ego of α-aminoadipic semialdehyde, in Antiquitin deficiency.
Struys E, Bok L, Emal D, Houterman S, Willemsen M, Jakobs C
J Inherit Metab Dis. 2012; 35(5):909-16.
PMID: 22249334
PMC: 3432202.
DOI: 10.1007/s10545-011-9443-0.
Global host metabolic response to Plasmodium vivax infection: a 1H NMR based urinary metabonomic study.
Sengupta A, Ghosh S, Basant A, Malusare S, Johri P, Pathak S
Malar J. 2011; 10:384.
PMID: 22196439
PMC: 3298531.
DOI: 10.1186/1475-2875-10-384.
Epilepsy and inborn errors of metabolism in children.
Wolf N, Garcia-Cazorla A, Hoffmann G
J Inherit Metab Dis. 2009; 32(5):609.
PMID: 19642011
DOI: 10.1007/s10545-009-1171-3.
New treatment paradigms in neonatal metabolic epilepsies.
Pearl P
J Inherit Metab Dis. 2009; 32(2):204-13.
PMID: 19234868
DOI: 10.1007/s10545-009-1045-8.
Pyridoxal phosphate dependency, a newly recognized treatable catastrophic epileptic encephalopathy.
Pearl P, Gospe S
J Inherit Metab Dis. 2009; 30(1):2-4.
PMID: 19165905
DOI: 10.1007/s10545-008-9974-1.
Clinical features and the management of pyridoxine-dependent and pyridoxine-responsive seizures: review of 63 North American cases submitted to a patient registry.
Basura G, Hagland S, Wiltse A, Gospe Jr S
Eur J Pediatr. 2008; 168(6):697-704.
PMID: 18762976
DOI: 10.1007/s00431-008-0823-x.
Recent advances in amino acid and organic acid metabolism.
Leonard J
J Inherit Metab Dis. 2007; 30(2):134-8.
PMID: 17237988
DOI: 10.1007/s10545-006-0524-4.
Pyridoxal 5'-phosphate may be curative in early-onset epileptic encephalopathy.
Hoffmann G, Schmitt B, Windfuhr M, Wagner N, Strehl H, Bagci S
J Inherit Metab Dis. 2007; 30(1):96-9.
PMID: 17216302
DOI: 10.1007/s10545-006-0508-4.
Pyridoxine-dependent seizures in Dutch patients: diagnosis by elevated urinary alpha-aminoadipic semialdehyde levels.
Bok L, Struys E, Willemsen M, Been J, Jakobs C
Arch Dis Child. 2006; 92(8):687-9.
PMID: 17088338
PMC: 2083882.
DOI: 10.1136/adc.2006.103192.
Diagnosis and treatment of neurotransmitter disorders.
Pearl P, Hartka T, Taylor J
Curr Treat Options Neurol. 2006; 8(6):441-50.
PMID: 17032564
DOI: 10.1007/s11940-006-0033-7.
B6-responsive disorders: a model of vitamin dependency.
Clayton P
J Inherit Metab Dis. 2006; 29(2-3):317-26.
PMID: 16763894
DOI: 10.1007/s10545-005-0243-2.
